Navigation Links
Source Precision Medicine, Inc. d/b/a Source MDx Announces Foundational Patents Will Be Offered for Sale on April 29, 2011
Date:3/21/2011

WELLESLEY HILLS, Mass., March 21, 2011 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Source Precision Medicine, Inc. d/b/a/ Source MDx ("Source MDx") announced that the foundational patents of Source MDx will be offered for sale on April 29, 2011.

Source MDx holds a broad-based, array of patents that cover technical aspects of RNA transcript measurement, concepts surrounding normal ranges in healthy human subjects ("normals") and statistical methods generating multi-gene models for the discrimination of normals versus disease.  Key patents comprise the foundation of Source MDx's intellectual property portfolio.  These include:

A.  Systems and Methods for Characterizing a Biological Condition or Agent using Precision Gene Expression (#6,692,916 issued 02.17.04)

B.  Identification, Monitoring and Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles (#6,940,439 issued 11.01.05)

C.  Identification, Monitoring and Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles (#6,964,850 pending)

Persons interested in bidding must sign a Confidentiality Disclosure Agreement ("CDA") obtained from Finn's office – jffinnjr@finnwarnkegayton or 781-27-8840.  They will then receive a bid package.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr., C.P.A. is the founding partner of the firm Finn, Warnke & Gayton LLP of Wellesley Hills, Massachusetts (www.finnwarnkegayton.com).  He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as Assignee for the Benefit of Creditors and Liquidating Agent for corporations.  He has been involved in a number of loan workouts and bankruptcy cases for thirty-six (36) years.  His most recent Assignments for the Benefit of Creditors in the biotech field include Spherics, Inc., ActivBioics, Inc. Prospect Therapeutics, Inc. and Epix Pharmaceuticals, Inc.

For further information, please contact Joseph F. Finn, Jr., C.P.A. at 781-237-8840 or jffinnjr@finnwarnkegatyon.com


'/>"/>
SOURCE Joseph F. Finn, Jr., C.P.A.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Scientific Resources Announces New Distributor Syner-Med Placing Kidz-Med VeraTemp in the United Kingdom and Ireland
2. MPR Launches Patient Advisor—A Drug and Health Information Resource for Consumers From the Trusted Source Healthcare Practitioners Rely On
3. Source Precision Medicine, Inc., dba SourceMDx Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. of the firm of Finn, Warnke & Gayton, LLP
4. Global Sources extends its contract with AsiaWorld-Expo to host China Sourcing Fairs in Hong Kong through 2014
5. American Scientific Resources Announces New Distributor HospiServices Placing Kidz-Med VeraTemp in Middle Eastern and African Pharmacies
6. American Scientific Resources Rebrands Non-Contact Thermometer for Mass Market Consumer Appeal
7. Merz Launches New Online Resource for Patients with Focal Dystonias
8. BioMedix™ Now Exclusive Industry Distributor of the APMA Coding Resource Center
9. New Online Resource Available Specifically for Patients and Their Caregivers Following a Heart Stent Procedure
10. American Scientific Resources, Inc. Announces S-1 Registration Statement Effective; Commences Public Reporting Requirements
11. FDA Launches Website To Help Regulated Industries Save Time, Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... 7, 2017 Endo International plc (NASDAQ: ... the Hon. Joseph R. Goodwin , U.S. District ... West Virginia , entered a case management order ... System Products Liability Litigation (the "MDL") that includes a ... provide expert disclosures on specific causation within one hundred ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... Schneider Insurance and ... to clients in southern Montana, is announcing a focused charity effort to gather ... outreach programs offered by Zoo Montana provide students with current knowledge on the ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with the ... for families with children receiving treatment in nearby hospitals. , Ronald McDonald House ...
(Date:6/27/2017)... , ... June 27, 2017 , ... DrugDev ... is whether they can trust the sponsor to pay them correctly and on time. ... and CROs establish payment strategies that encourage sites to work on their studies. , ...
(Date:6/27/2017)... MA (PRWEB) , ... June 27, 2017 , ... The ... Senate bill to repeal and replace the 2010 Patient Protection and Affordable Care Act ... compared with what would be expected under current law. , More than 20 million ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article on medGadget ... $6.81 billion by the year 2024 according to a new report. The article also ... made from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center ...
Breaking Medicine News(10 mins):